ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,066.00
-0.07%
다우존스 지수
40,003.59
0.34%
Bitcoin
66,984.25
-0.14%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Pacira BioSciences Inc (PCRX)

  7. Pacira BioSciences Inc (PCRX) 뉴스

PCRX

Pacira BioSciences (PCRX)

Pacira BioSciences Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PCRX
일자시간출처헤드라인심볼기업
2024/05/1505:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
2024/05/1020:00GlobeNewswire Inc.Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029NASDAQ:PCRXPacira BioSciences Inc
2024/05/0905:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
2024/05/0905:05GlobeNewswire Inc.Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior NotesNASDAQ:PCRXPacira BioSciences Inc
2024/05/0805:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PCRXPacira BioSciences Inc
2024/05/0805:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
2024/05/0805:00GlobeNewswire Inc.Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase programNASDAQ:PCRXPacira BioSciences Inc
2024/05/0721:00GlobeNewswire Inc.Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:PCRXPacira BioSciences Inc
2024/04/3021:00GlobeNewswire Inc.Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024NASDAQ:PCRXPacira BioSciences Inc
2024/04/0221:00GlobeNewswire Inc.Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PCRXPacira BioSciences Inc
2024/03/1320:00GlobeNewswire Inc.Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the KneeNASDAQ:PCRXPacira BioSciences Inc
2024/03/0622:00GlobeNewswire Inc.Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare ConferenceNASDAQ:PCRXPacira BioSciences Inc
2024/03/0105:33Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PCRXPacira BioSciences Inc
2024/02/2922:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
2024/02/2922:00GlobeNewswire Inc.Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:PCRXPacira BioSciences Inc
2024/02/2222:00GlobeNewswire Inc.Pacira to Report 2023 Financial Results on Thursday February 29, 2024NASDAQ:PCRXPacira BioSciences Inc
2024/02/1522:36GlobeNewswire Inc.Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After BunionectomyNASDAQ:PCRXPacira BioSciences Inc
2024/02/0806:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/02/0722:00GlobeNewswire Inc.Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.NASDAQ:PCRXPacira BioSciences Inc
2024/02/0200:45PR Newswire (US)G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball TeamsNASDAQ:PCRXPacira BioSciences Inc
2024/01/0507:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/01/0507:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/01/0507:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/01/0507:18Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/01/0507:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
2024/01/0507:00GlobeNewswire Inc.Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 RevenuesNASDAQ:PCRXPacira BioSciences Inc
2024/01/0322:00GlobeNewswire Inc.Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PCRXPacira BioSciences Inc
2023/12/2121:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
2023/12/2121:30GlobeNewswire Inc.Pacira Appoints Frank D. Lee as Chief Executive OfficerNASDAQ:PCRXPacira BioSciences Inc
2023/12/0809:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
 검색 관련기사 보기:NASDAQ:PCRX

최근 히스토리

NYSE
DIS
Walt Disney
USI
USTECH100
US Tech 100
NYSE
MRK
Merck
NASDAQ
AMZN
Amazon.com
FX
USDJPY
US Dollar vs Yen
USOTC
BNPQY
BNP Paribas (QX)
CCOM
US30
US 30
CCOM
SILVER
SILVER
COIN
BTCUSD
Bitcoin
AMEX
XLV
Health Care Select Sector
NYSE
VZ
Verizon Communications
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US100
US Tech 100
USOTC
ADDYY
Adidas (QX)
CCOM
US500
US 500
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유